luzindole has been researched along with lysine in 1 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | luzindole (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cevik-Aras, H; Ekström, J | 1 |
1 other study(ies) available for luzindole and lysine
| Article | Year |
|---|---|
Anti-inflammatory action of cholecystokinin and melatonin in the rat parotid gland.
Topics: Animals; Anti-Inflammatory Agents; Escherichia coli; Hormone Antagonists; Injections, Intraperitoneal; Lipopolysaccharides; Lysine; Melatonin; Neutrophil Infiltration; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Organ Size; Parasympathectomy; Parotid Gland; Parotitis; Peroxidase; Proglumide; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Melatonin, MT2; Sincalide; Sympathectomy; Tryptamines | 2010 |